Administration of EGFR inhibitors significantly inhibited EGFR phosphorylation, decreased the expression of TGF-β, collagen I and CTGF in the myocardium of animals subjected to HFD, which led to less cardiac fibrosis and dysfunction. This evidence concerns the gene TGFB1 and fibrosis.